MARTINELLI, Erika

MARTINELLI, Erika  

Dipartimento di Medicina di Precisione  

Mostra records
Risultati 1 - 20 di 194 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
[Preclinical and clinical results with the epidermal growth factor receptor inhibitor Gefitinib (ZD1839, Iressa)] 1-gen-2004 Di Cosimo, S; Ferretti, G; Milella, M; Martinelli, E; Alimonti, A; Papaldo, P; Carlini, P; Fabi, A; Matar, P; Cognetti, F
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 1-gen-2019 De Falco, V.; Natalicchio, M. I.; Napolitano, S.; Coppola, N.; Conzo, G.; Martinelli, E.; Zanaletti, N.; Vitale, P.; Giunta, E. F.; Vietri, M. T.; Vitiello, P. P.; Ciardiello, D.; Marinaccio, A.; De Vita, F.; Ciardiello, F.; Troiani, T.
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 1-gen-2011 DE VITA, Ferdinando; Orditura, Michele; Martinelli, Erika; Vecchione, L; Innocenti, R; Sileni, Vc; Pinto, C; Di Maio, M; Farella, A; Troiani, Teresa; Morgillo, Floriana; Napolitano, Vincenzo; Ancona, E; Di Martino, N; Ruol, A; Galizia, Gennaro; Del Genio, A; Ciardiello, Fortunato
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 1-gen-2019 Ciaramella, Vincenza; Sasso, Ferdinando Carlo; DI Liello, Raimondo; Corte, Carminia Maria Della; Barra, Giusi; Viscardi, Giuseppe; Esposito, Giovanna; Sparano, Francesca; Troiani, Teresa; Martinelli, Erika; Orditura, Michele; De Vita, Ferdinando; Ciardiello, Fortunato; Morgillo, Floriana
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 1-gen-2010 Orditura, Michele; DE VITA, Ferdinando; Muto, P; Vitiello, F; Murino, P; Lieto, Eva; Vecchione, L; Romano, A; Martinelli, Erika; Renda, A; Ferraraccio, Franca; DEL GENIO, A; Ciardiello, Fortunato; Galizia, Gennaro
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study 1-gen-2022 Mentrasti, Giulia; Cantini, Luca; Zichi, Clizia; D'Ostilio, Nicola; Gelsomino, Fabio; Martinelli, Erika; Chiari, Rita; La Verde, Nicla; Bisonni, Renato; Cognigni, Valeria; Pinterpe, Giada; Pecci, Federica; Migliore, Antonella; Aimar, Giacomo; De Vita, Francesca; Traisci, Donatella; Spallanzani, Andrea; Martini, Giulia; Nicolardi, Linda; Cona, Maria Silvia; Baleani, Maria Giuditta; Rocchi, Marco Luigi Bruno; Berardi, Rossana
Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ 1-gen-2021 Rao, S.; Guren, M. G.; Khan, K.; Brown, G.; Renehan, A. G.; Steigen, S. E.; Deutsch, E.; Martinelli, E.; Arnold, D.
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 1-gen-2009 Martinelli, Erika; DE PALMA, Raffaele; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial 1-gen-2022 Della Corte, C. M.; Fasano, M.; Ciaramella, V.; Cimmino, F.; Cardnell, R.; Gay, C. M.; Ramkumar, K.; Diao, L.; Di Liello, R.; Viscardi, G.; Famiglietti, V.; Ciardiello, D.; Martini, G.; Napolitano, S.; Tuccillo, C.; Troiani, T.; Martinelli, E.; Wang, J.; Byers, L.; Morgillo, F.; Ciardiello, F.
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 1-gen-2011 Morgillo, Floriana; D'Aiuto, E; Troiani, Teresa; Martinelli, Erika; Cascone, T; DE PALMA, Raffaele; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 1-gen-2019 Della Corte, C. M.; Barra, G.; Ciaramella, V.; Di Liello, R.; Vicidomini, G.; Zappavigna, S.; Luce, A.; Abate, M.; Fiorelli, A.; Caraglia, M.; Santini, M.; Martinelli, E.; Troiani, T.; Ciardiello, F.; Morgillo, F.
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells 1-gen-2013 Martinelli, Erika; Troiani, Teresa; D’Aiuto, Elena; Morgillo, Floriana; Vitagliano, Donata; Capasso, Anna; Costantino, Sarah; Ciuffreda, Loreta Pia; Merolla, Francesco; Vecchione, Loredana; Vriendt, Veerle De; Tejpar, Sabine; Nappi, Anna; Sforza, Vincenzo; Martini, Giulia; Berrino, Liberato; DE PALMA, Raffaele; Ciardiello, Fortunato
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 1-gen-2011 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato; Ciardiello, F.
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor 1-gen-2005 Tuccillo, C; Romano, Marco; Troiani, Teresa; Martinelli, Erika; Morgillo, Floriana; DE VITA, Ferdinando; Bianco, R; Fontanini, G; Bianco, Ra; Tortora, G; Ciardiello, Fortunato
antitumor activity of zd6474, a VEGFR-2 and EGFR small molecule tyrosine kinase inhibitor in combination with SC-236, a cicloxigenase-2 inhibitor 1-gen-2005 Tuccillo, C; Romano, Marco; Troiani, Teresa; Martinelli, Erika; Morgillo, Floriana; DE VITA, Ferdinando; Bianco, R; Fontanini, G; Bianco, R; Tortoa, G; Ciardiello, Fortunato
Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models 1-gen-2018 Della Corte, Carminia Maria; Ciaramella, Vincenza; Cardone, Claudia; La Monica, Silvia; Alfieri, Roberta; Petronini, Pier Giorgio; Malapelle, Umberto; Vigliar, Elena; Pepe, Francesco; Troncone, Giancarlo; Castellone, Maria Domenica; Troiani, Teresa; Martinelli, Erika; Ciardiello, Fortunato; Morgillo, Floriana
Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human BRAFV600E mutant colorectal cancer 1-gen-2023 Napolitano, Stefania; Woods, Melanie; Lee, Hey Min; De Falco, Vincenzo; Martini, Giulia; Della Corte, Carminia M; Martinelli, Erika; Famiglietti, Vincenzo; Ciardiello, Davide; Anderson, Amanda; Wall Fowlkes, Natalie; Villarreal, Oscar Eduardo; Sorokin, Alexey; Kanikarla, Preeti; Coker, Olu; Morris, Van; Altucci, Lucia; Tabernero, Josep; Troiani, Teresa; Ciardiello, Fortunato; Kopetz, Scott
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells 1-gen-2018 Ciaramella, V; DELLA CORTE, Carminia Maria; Di Mauro, C; Tomassi, S; Di Maro, S; Troiani, T; Martinelli, E; Bianco, R; Cosconati, S; Pierantoni, R; Meccariello, R; Chianese, R; Ciardiello, F; Morgillo, F.
Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFRdependent and in cetuximab-resistant human colorectal cancer cells 1-gen-2017 Napolitano, Stefania; Martini, Giulia; Martinelli, Erika; Corte, Carminia Maria Della; Morgillo, Floriana; Belli, Valentina; Cardone, Claudia; Matrone, Nunzia; Ciardiello, Fortunato; Troiani, Teresa
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors 1-gen-2011 Morgillo, Floriana; Cascone, T; D'Aiuto, E; Martinelli, Erika; Troiani, Teresa; Saintigny, P; DE PALMA, Raffaele; Heymach, Jv; Berrino, Liberato; Tuccillo, C; Ciardiello, Fortunato